Is there an interest in systematic serum screening for aspergillosis in COVID-19 patients in a medical ward?

Date publication

avril 2024

Journal

Infectious diseases now

Auteurs

Membres identifiés du Cancéropôle Est :
Pr HERBRECHT Raoul

Tous les auteurs :
Gerber V, Boehn L, Sabou M, Studer A, Ursenbach A, Hansmann Y, Herbrecht R, Lefebvre N, Letscher-Bru V, Danion F

Lien Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/38636842

Résumé

We evaluated the interest of systematic screening of serum fungal markers in patients hospitalized in a medical ward.

Mots clés

Aspergillosis, COVID-19, COVID-19-associated pulmonary aspergillosis, Fungal screening

Référence

Infect Dis Now. 2024 04 16;:104918